Tacrine-Based Hybrids: Past, Present, and Future
International Journal of Molecular Sciences · 15.01.2023 · 24 (2) · 1717
DOI: 10.3390/ijms24021717 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.01.2023. Verfasst von Anna Bubley und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1-3, Moscow 119991, Russia. Hauptthemen laut MEDLINE: Alzheimer Disease, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 203 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Education and Science of the Russian Federation.
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a neurodegenerative disorder which is characterized by β-amyloid (Aβ) aggregation, τ-hyperphosphorylation, and loss of cholinergic neurons. The other important hallmarks of AD are oxidative stress, metal dyshomeostasis, inflammation, and cell cycle dysregulation. Multiple therapeutic targets may be proposed for the development of anti-AD drugs, and the “one drug–multiple targets” strategy is of current interest. Tacrine (THA) was the first clinically approved cholinesterase (ChE) inhibitor, which was withdrawn due to high hepatotoxicity. However, its high potency in ChE inhibition, low molecular weight, and simple structure make THA a promising scaffold for developing multi-target agents. In this review, we summarized THA-based hybrids published from 2006 to 2022, thus providing an overview of strategies that have been used in drug design and approaches that have resulted in significant cognitive improvements and reduced hepatotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1-3, Moscow 119991, Russia.
- Department of Materials Science of Semiconductors and Dielectrics, National University of Science and Technology (MISIS), Leninskiy Prospect 4, Moscow 119049, Russia.
ORCID-Profile: Peter Gorelkin, Elena Beloglazkina
Förderung
- The Ministry of Education and Science of the Russian Federation
Zitieren
APA
Bubley, A., Erofeev, A., Gorelkin, P., Beloglazkina, E., Majouga, A., & Krasnovskaya, O. (2023). Tacrine-Based Hybrids: Past, Present, and Future. International Journal of Molecular Sciences, 24(2), 1717. https://doi.org/10.3390/ijms24021717
Vancouver
Bubley A, Erofeev A, Gorelkin P, Beloglazkina E, Majouga A, Krasnovskaya O. Tacrine-Based Hybrids: Past, Present, and Future. International Journal of Molecular Sciences. 2023;24(2):1717. doi:10.3390/ijms24021717
BibTeX
@article{Bubley2023,
author = {Bubley, Anna and Erofeev, Alexaner and Gorelkin, Peter and Beloglazkina, Elena and Majouga, Alexander and Krasnovskaya, Olga},
title = {Tacrine-Based Hybrids: Past, Present, and Future},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {2},
pages = {1717},
doi = {10.3390/ijms24021717}
}
EUVIMED